GB202108194D0 - Bacteriophage composition, bacteriostat, and use thereof - Google Patents

Bacteriophage composition, bacteriostat, and use thereof

Info

Publication number
GB202108194D0
GB202108194D0 GBGB2108194.8A GB202108194A GB202108194D0 GB 202108194 D0 GB202108194 D0 GB 202108194D0 GB 202108194 A GB202108194 A GB 202108194A GB 202108194 D0 GB202108194 D0 GB 202108194D0
Authority
GB
United Kingdom
Prior art keywords
bacteriostat
bacteriophage composition
bacteriophage
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2108194.8A
Other versions
GB2605465A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Academy of Agricultural Sciences
Original Assignee
Jiangsu Academy of Agricultural Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Academy of Agricultural Sciences filed Critical Jiangsu Academy of Agricultural Sciences
Publication of GB202108194D0 publication Critical patent/GB202108194D0/en
Publication of GB2605465A publication Critical patent/GB2605465A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/40—Viruses, e.g. bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB2108194.8A 2021-03-29 2021-06-08 Bacteriophage composition, bacteriostat, and use thereof Pending GB2605465A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110332620.5A CN113061582B (en) 2021-03-29 2021-03-29 Phage composition, bacteriostatic agent and application thereof

Publications (2)

Publication Number Publication Date
GB202108194D0 true GB202108194D0 (en) 2021-07-21
GB2605465A GB2605465A (en) 2022-10-05

Family

ID=76564085

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2108194.8A Pending GB2605465A (en) 2021-03-29 2021-06-08 Bacteriophage composition, bacteriostat, and use thereof

Country Status (2)

Country Link
CN (1) CN113061582B (en)
GB (1) GB2605465A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113583976A (en) * 2021-08-05 2021-11-02 瑞科盟(青岛)生物工程有限公司 Phage composition and application thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113583975B (en) * 2021-08-05 2022-10-21 瑞科盟(青岛)生物工程有限公司 Phage composition and application thereof
CN113881607A (en) * 2021-11-17 2022-01-04 宜兴市天石饲料有限公司 Research and development method for preventing and treating avian clostridium perfringens

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101519651B (en) * 2009-04-08 2011-05-04 江苏省农业科学院 Shigella flexneri phage strain and application thereof
US10711252B2 (en) * 2015-01-23 2020-07-14 Intralytix, Inc. Shigella bacteriophages and uses thereof
KR102016922B1 (en) * 2016-12-13 2019-10-21 주식회사 옵티팜 Novel pathogenic Escherichia coli specific bacteriophage EC10 and antibacterial composition comprising the same
CN108359644B (en) * 2018-02-07 2019-08-02 青岛诺安百特生物技术有限公司 A kind of wide range salmonella bacteriophage and its application
GEP20197030B (en) * 2018-05-02 2019-10-25 Biochimpharm Jsc Antimicrobial composition against gastrointestinal infections and the use of thereof
US20210138006A1 (en) * 2018-07-13 2021-05-13 Brigham Young University Systems, Methods, and Compositions for Treating or Preventing Bacterial Infection and for Reducing or Preventing Bacterial Overpopulation
GB201815483D0 (en) * 2018-09-24 2018-11-07 Univ Leicester Therapeutic bacteriophages
CN111662880B (en) * 2020-05-25 2022-06-17 江苏省农业科学院 Clostridium perfringens bacteriophage, bacteriostatic agent containing bacteriophage, preparation method and application
CN111789132A (en) * 2020-07-04 2020-10-20 菲吉乐科(南京)生物科技有限公司 Novel composite preparation and application thereof in bacterial diseases

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113583976A (en) * 2021-08-05 2021-11-02 瑞科盟(青岛)生物工程有限公司 Phage composition and application thereof
CN113583976B (en) * 2021-08-05 2022-07-01 瑞科盟(青岛)生物工程有限公司 Phage composition and application thereof

Also Published As

Publication number Publication date
CN113061582B (en) 2022-07-05
GB2605465A (en) 2022-10-05
CN113061582A (en) 2021-07-02

Similar Documents

Publication Publication Date Title
GB202108194D0 (en) Bacteriophage composition, bacteriostat, and use thereof
IL288816A (en) Aminobenzazepine compounds, immunoconjugates, and uses thereof
IL291760A (en) Amide-linked, aminobenzazepine immunoconjugates, and uses thereof
IL290979A (en) Antibody-drug conjugate comprising antibody against human ror1, and use for the same
GB202106282D0 (en) Composition and use thereof
IL287905A (en) Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, and use thereof
EP3786167C0 (en) Diaryl macrocyclic compound and pharmaceutical composition, and use thereof
EP4074335A4 (en) Immunostimulatory composition and use thereof
PL3954689T3 (en) Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereof
EP4190346A4 (en) Composition for preventing or treating inflammatory diseases, and use thereof
GB202108948D0 (en) Copolymers, their preparation and use
EP4209505A4 (en) Composition comprising peptide, and use thereof
AU2022245340A1 (en) 2-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereof
EP4237092A4 (en) Stat-activated macrophages, compositions, and uses thereof
GB2609814B (en) Terpenophenolic compounds and their use
EP4096705A4 (en) Alpha-1-antitrypsin mutants, compositions comprising same, and use thereof
PL4028001T3 (en) Rifabutin treatment methods, uses, and compositions
GB2579240B (en) New processes, compositions and medical uses
ZA202209705B (en) Anti-plant-virus composition, anti-plant-virus agent and application thereof
GB202101543D0 (en) Vaping e-liquid composition and the use thereof
GB202400788D0 (en) Neorhizobium SP, and use thereof
GB202014427D0 (en) Composition and use
GB202102228D0 (en) Composition and use thereof
GB202306456D0 (en) Composition, methods and uses
GB202107977D0 (en) Method, composition and use